AlphaFold predicted structure
LPIN1 · Q14693

Mean pLDDT
60.4/ 100
Low
890 residues
Confidence breakdown
- Very high(≥ 90)24%
- Confident(70–90)15%
- Low(50–70)10%
- Very low(< 50)50%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
lipin 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Acute rhabdomyolysis
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalLimb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies
BIALLELIC, autosomal or pseudoautosomalRhabdomyolysis and metabolic muscle disorders
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalArthrogryposis
Childhood onset dystonia, chorea or related movement disorder
Hyperammonaemia
myoglobinuria, acute recurrent, autosomal recessive
hereditary recurrent myoglobinuria
Acute rhabdomyolysis
cardiac arrest
neutropenia
response to COVID-19 vaccine
Lymphadenopathy
ovarian dysfunction
Abnormal male internal genitalia morphology
placental abruption
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Phosphatidate phosphatase LPIN1
Acts as a magnesium-dependent phosphatidate phosphatase enzyme which catalyzes the conversion of phosphatidic acid to diacylglycerol during triglyceride, phosphatidylcholine and phosphatidylethanolamine biosynthesis and therefore controls the metabolism of fatty acids at different levels (PubMed:20231281, PubMed:23426360, PubMed:29765047, PubMed:31695197). Is involved in adipocyte differentiation (By similarity). Recruited at the mitochondrion outer membrane and is involved in mitochondrial fission by converting phosphatidic acid to diacylglycerol (By similarity). Acts also as nuclear transcriptional coactivator for PPARGC1A/PPARA regulatory pathway to modulate lipid metabolism gene expression (By similarity)
LPIN1 · Q14693

Mean pLDDT
60.4/ 100
Low
890 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0